G1 Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for G1 Therapeutics stock had an average target of $3.50, with a low estimate of $3.00 and a high estimate of $4.00.

Price Target: $3.50 (-51.05%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$3.00	$3.50	n/a	$4.00
Change	-58.04%	-51.05%	n/a	-44.06%

Analyst Ratings

The average analyst rating for G1 Therapeutics stock from 4 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

75.01M

from 82.51M

-9.09%

from 82.51M

Revenue Next Year

96.38M

from 75.01M

28.49%

from 75.01M

EPS This Year

-0.42

from -0.93

EPS Next Year

0.05

from -0.42

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-	45.29M	31.48M	51.30M	82.51M	75.01M	96.38M
Revenue Growth	-	-	-30.49%	62.98%	60.84%	-9.09%	28.49%
EPS	-3.27	-2.62	-3.54	-3.38	-0.93	-0.42	0.05
Forward PE	-	-	-	-	-	-	133.52
No. Analysts	-	-	-	-	-	7	7

Revenue Forecast

Revenue	2024	2025
High	84.9M	106.4M
Avg	75.0M	96.4M
Low	67.6M	82.3M

Revenue Growth

Revenue Growth	2024	2025
High	2.9%	41.8%
Avg	-9.1%	28.5%
Low	-18.0%	9.7%

EPS Forecast

EPS	2024	2025
High	-0.14	0.25
Avg	-0.42	0.05
Low	-0.58	-0.03

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-